Health ASCO 2023: IDH mutation and improved cognitive functions in brain tumor patients by Alexandra Hartman Editor-in-Chief June 4, 2023 written by Alexandra Hartman Editor-in-Chief June 4, 2023 54 2023-06-04 12:19:42 – ASCO 2023 ASCO 2023 Patients with this tumor with the IDH 1 and 2 mutation improve their motor and cognitive functions, in addition to avoiding long-term relapses. Grade 2 gliomas with a mutation in the IDH gene are malignant brain tumors that cause considerable morbidity and premature death. 1685882522 #Vorasidenib #stops #grade #glioma #surgery #delays #chemo #radium Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X 0 comments 0 FacebookTwitterPinterestEmail Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity. previous post Despite Dementia, Bruce Willis Enjoys a Day at Disneyland with Wife and Children next post Amazon is negotiating with US carriers to provide low-cost mobile phone service You may also like Certainty & Your Brain: How Affect Drives Goal... February 26, 2026 Bolivia: Solar Plant & Water Treatment Funded by... February 26, 2026 IVF, Surrogacy & Egg Freezing: The Evolution of... February 26, 2026 Early HIV Treatment in Kids: Potential for Remission February 26, 2026 Unlock Full Access: Exclusive Content from €1/Month February 26, 2026 8-Minute Bed Routine to Tighten Arm Flab After... February 26, 2026 Caen: L’hôpital des nounours pour familiariser les enfants... February 26, 2026 Declining Birth Rates & the Future of Pediatrics:... February 26, 2026 ChatGPT Health Risks: AI Misses Urgent Care &... February 26, 2026 Sleep, Heart Health & Diet: Latest Health News February 26, 2026 Leave a Comment Cancel Reply Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
